Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dinalbuphine sebacate for analgesia and recovery after bilateral total knee arthroplasty
TCTR20260922001Phase 2Not yet recruiting
- Sponsor
- Burin Sutthapakti, M.D.
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dinalbuphine sebacate in knee osteoarthritis (OA), sponsored by Burin Sutthapakti, M.D.. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dinalbuphine sebacate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on TCTR20260922001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260922001.